Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lassa Fever | 5 | 2024 | 97 | 0.700 |
Why?
|
Neurosecretory Systems | 1 | 2019 | 231 | 0.610 |
Why?
|
Patient Care | 1 | 2021 | 640 | 0.510 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1086 | 0.500 |
Why?
|
Glioma | 2 | 2020 | 3401 | 0.490 |
Why?
|
Neuropeptides | 1 | 2020 | 942 | 0.490 |
Why?
|
Neuroendocrine Tumors | 1 | 2020 | 594 | 0.480 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1206 | 0.400 |
Why?
|
Radiation Injuries | 1 | 2019 | 1180 | 0.400 |
Why?
|
Lassa virus | 4 | 2024 | 97 | 0.390 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8863 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3703 | 0.310 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11124 | 0.300 |
Why?
|
Orthopedics | 2 | 2011 | 904 | 0.250 |
Why?
|
Musculoskeletal Diseases | 1 | 2011 | 581 | 0.250 |
Why?
|
Educational Measurement | 1 | 2011 | 1210 | 0.230 |
Why?
|
Teaching | 1 | 2011 | 1174 | 0.220 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6364 | 0.210 |
Why?
|
Education, Medical, Undergraduate | 1 | 2011 | 1008 | 0.200 |
Why?
|
Semen | 1 | 2023 | 316 | 0.190 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.190 |
Why?
|
Craniopharyngioma | 1 | 2023 | 281 | 0.190 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Curriculum | 1 | 2011 | 3605 | 0.150 |
Why?
|
Standard of Care | 1 | 2021 | 564 | 0.150 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 681 | 0.130 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1345 | 0.120 |
Why?
|
Confidence Intervals | 1 | 2020 | 2971 | 0.120 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2886 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 966 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20822 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
Prostate | 1 | 2020 | 1774 | 0.100 |
Why?
|
Genome, Viral | 1 | 2015 | 667 | 0.100 |
Why?
|
Visual Cortex | 1 | 2019 | 1149 | 0.100 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2012 | 171 | 0.090 |
Why?
|
Selection, Genetic | 2 | 2013 | 914 | 0.090 |
Why?
|
Genetic Techniques | 1 | 2013 | 435 | 0.090 |
Why?
|
Linear Models | 1 | 2020 | 5952 | 0.090 |
Why?
|
Genome, Human | 2 | 2013 | 4420 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2183 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9687 | 0.080 |
Why?
|
Bone Plates | 1 | 2011 | 468 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9959 | 0.080 |
Why?
|
Interleukins | 1 | 2012 | 791 | 0.070 |
Why?
|
RNA, Viral | 1 | 2015 | 2902 | 0.070 |
Why?
|
Radiology | 1 | 2021 | 2100 | 0.070 |
Why?
|
Cholera | 1 | 2013 | 785 | 0.070 |
Why?
|
Disease Progression | 2 | 2023 | 13284 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.070 |
Why?
|
Radius Fractures | 1 | 2011 | 501 | 0.070 |
Why?
|
Humans | 20 | 2024 | 744343 | 0.060 |
Why?
|
Clinical Competence | 2 | 2011 | 4687 | 0.060 |
Why?
|
Fracture Fixation, Internal | 1 | 2011 | 917 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2011 | 2110 | 0.060 |
Why?
|
Neoplasms | 2 | 2024 | 21683 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Schools, Medical | 1 | 2011 | 880 | 0.060 |
Why?
|
Nigeria | 2 | 2018 | 733 | 0.060 |
Why?
|
Africa, Western | 2 | 2015 | 154 | 0.060 |
Why?
|
Risk Assessment | 3 | 2021 | 23338 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1940 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9438 | 0.060 |
Why?
|
Male | 9 | 2023 | 350118 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 401 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2010 | 1076 | 0.050 |
Why?
|
Leadership | 1 | 2010 | 1357 | 0.050 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.050 |
Why?
|
Prospective Studies | 2 | 2019 | 53288 | 0.050 |
Why?
|
Cryotherapy | 1 | 2021 | 155 | 0.050 |
Why?
|
Mutation | 4 | 2024 | 29786 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13695 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12261 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 629 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3597 | 0.040 |
Why?
|
Female | 8 | 2024 | 380194 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 12804 | 0.040 |
Why?
|
Students, Medical | 1 | 2011 | 1862 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2386 | 0.040 |
Why?
|
Fever | 1 | 2024 | 1616 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2015 | 131 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2024 | 6386 | 0.030 |
Why?
|
Zoonoses | 1 | 2015 | 185 | 0.030 |
Why?
|
NF-kappa B | 2 | 2013 | 2499 | 0.030 |
Why?
|
Sierra Leone | 1 | 2014 | 166 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 701 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
Rivers | 1 | 2013 | 66 | 0.030 |
Why?
|
Toll-Like Receptor 5 | 1 | 2013 | 39 | 0.030 |
Why?
|
Ebolavirus | 1 | 2015 | 263 | 0.030 |
Why?
|
Brain | 1 | 2019 | 26385 | 0.030 |
Why?
|
Flagellin | 1 | 2013 | 125 | 0.030 |
Why?
|
Phylogeography | 1 | 2012 | 82 | 0.030 |
Why?
|
Ribavirin | 1 | 2014 | 395 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2013 | 186 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2023 | 4803 | 0.030 |
Why?
|
Immunoassay | 1 | 2014 | 752 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 428 | 0.020 |
Why?
|
Middle Aged | 3 | 2019 | 213383 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 1035 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1076 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7301 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2011 | 15295 | 0.020 |
Why?
|
Models, Genetic | 1 | 2019 | 3494 | 0.020 |
Why?
|
Wrist Injuries | 1 | 2011 | 208 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14722 | 0.020 |
Why?
|
Inflammasomes | 1 | 2013 | 495 | 0.020 |
Why?
|
Fracture Healing | 1 | 2011 | 427 | 0.020 |
Why?
|
Seasons | 1 | 2014 | 1493 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2011 | 1014 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1900 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2263 | 0.020 |
Why?
|
Vibrio cholerae | 1 | 2013 | 806 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168757 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2297 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6196 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2902 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2019 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81183 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1578 | 0.020 |
Why?
|
Incidence | 2 | 2014 | 20947 | 0.020 |
Why?
|
Program Development | 1 | 2010 | 1316 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2019 | 77449 | 0.010 |
Why?
|
Joint Instability | 1 | 2011 | 792 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13408 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2014 | 3176 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 40561 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2114 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2488 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3420 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 7023 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3743 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2291 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 56430 | 0.010 |
Why?
|
Aged | 2 | 2019 | 163280 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 29144 | 0.010 |
Why?
|
Infant | 1 | 2014 | 35136 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 41006 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23403 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39050 | 0.010 |
Why?
|
Child | 1 | 2014 | 77709 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 85781 | 0.000 |
Why?
|
United States | 1 | 2010 | 69872 | 0.000 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_